<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2d1 20170631//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article" dtd-version="1.2d1" specific-use="production" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">MEDRXIV</journal-id>
<journal-title-group>
<journal-title>medRxiv</journal-title>
<abbrev-journal-title abbrev-type="publisher">medRxiv</abbrev-journal-title>
</journal-title-group>
<publisher>
<publisher-name>Cold Spring Harbor Laboratory</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1101/2021.06.28.21259639</article-id>
<article-version>1.2</article-version>
<article-categories>
<subj-group subj-group-type="hwp-journal-coll">
<subject>Otolaryngology</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Chemosensory dysfunctions induced by COVID-19 can persist up to 7 months: A study of over 700 healthcare workers</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1376-2421</contrib-id>
<name><surname>Bussi&#x00E8;re</surname><given-names>Nicholas</given-names></name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Mei</surname><given-names>Jie</given-names></name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>L&#x00E9;vesque-Boissonneault</surname><given-names>Cindy</given-names></name>
<degrees>MSc</degrees>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Blais</surname><given-names>Mathieu</given-names></name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Carazo</surname><given-names>Sara</given-names></name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Gros-Louis</surname><given-names>Francois</given-names></name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>De Serres</surname><given-names>Gaston</given-names></name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7270-6115</contrib-id>
<name><surname>Dupr&#x00E9;</surname><given-names>Nicolas</given-names></name>
<degrees>MD, MSc, FRCP FAAN</degrees>
<xref ref-type="aff" rid="a5">5</xref>
<xref ref-type="aff" rid="a6">6</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8863-3982</contrib-id>
<name><surname>Frasnelli</surname><given-names>Johannes</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
<aff id="a1"><label>1</label><institution>Department of Anatomy, Universit&#x00E9; du Qu&#x00E9;bec &#x00E0; Trois-Rivi&#x00E8;res</institution>, Trois-Rivi&#x00E8;res, QC, <country>Canada</country></aff>
<aff id="a2"><label>2</label><institution>Axe M&#x00E9;decine r&#x00E9;g&#x00E9;n&#x00E9;ratrice, CHU de Qu&#x00E9;bec&#x2013;Universit&#x00E9; Laval</institution>, Qu&#x00E9;bec City, QC, <country>Canada</country></aff>
<aff id="a3"><label>3</label><institution>Faculty of Medicine, Department of Surgery, Universit&#x00E9; Laval</institution>, Qu&#x00E9;bec City, QC, <country>Canada</country></aff>
<aff id="a4"><label>4</label><institution>Institut National de Sant&#x00E9; Publique du Qu&#x00E9;bec</institution>, Qu&#x00E9;bec City, QC, <country>Canada</country></aff>
<aff id="a5"><label>5</label><institution>Faculty of Medicine, Department of Medicine, Universit&#x00E9; Laval</institution>, Qu&#x00E9;bec City, QC, <country>Canada</country></aff>
<aff id="a6"><label>6</label><institution>Axe Neurosciences, CHU de Qu&#x00E9;bec&#x2013;Universit&#x00E9; Laval</institution>, Qu&#x00E9;bec City, QC, <country>Canada</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label><bold>Correspondence to be sent to</bold> : Johannes Frasnelli MD, Universit&#x00E9; du Qu&#x00E9;bec &#x00E0; Trois-Rivi&#x00E8;res, 3351, boul. des Forges, C.P. 500, Trois-Rivi&#x00E8;res, QC G9A 5H7 Canada, Email: <email>johannes.a.frasnelli@uqtr.ca</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<year>2021</year>
</pub-date>
<elocation-id>2021.06.28.21259639</elocation-id>
<history>
<date date-type="received">
<day>28</day>
<month>6</month>
<year>2021</year>
</date>
<date date-type="rev-recd">
<day>06</day>
<month>7</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>06</day>
<month>7</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2021, Posted by Cold Spring Harbor Laboratory</copyright-statement>
<copyright-year>2021</copyright-year>
<license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/"><license-p>This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link></license-p></license>
</permissions>
<self-uri xlink:href="21259639.pdf" content-type="pdf" xlink:role="full-text"/>
<abstract>
<title>Abstract</title>
<p>Several studies have revealed either self-reported chemosensory alterations in large groups or objective quantified chemosensory impairments in smaller populations of patients diagnosed with COVID-19. However, due to the great variability in published results regarding COVID-19-induced chemosensory impairments and their follow-up, prognosis for chemosensory functions in patients with such complaints remains unclear. Our objective is to describe the various chemosensory alterations associated with COVID-19 and their prevalence and evolution after infection. A cross-sectional study of 704 healthcare workers with a RT-PCR confirmed SARS-CoV-2 infection between 28/2/2020 and 14/6/2020 was conducted 3 to 7 months after onset of symptoms. Data were collected with an online questionnaire. Outcomes included differences in reported chemosensory self-assessment of olfactory, gustatory, and trigeminal functions across time points and Chemosensory Perception Test scores from an easy-to-use at-home self-administered chemosensory test. Among the 704 participants, 593 (84.2%) were women, the mean (SD) age was 42 (12) years, and the questionnaire was answered on average 4.8 (0.8) months after COVID-19. During COVID-19, a decrease in olfactory, gustatory, and trigeminal sensitivities were reported by 81.3%, 81.5% and 48.0% respectively. Three to seven months later, reduced sensitivity was still reported by 52.0%, 41.9% and 23.3% respectively. Chemosensory Perception Test scores indicate that 19.5% of participants had objective olfactory impairment. These data suggest a significant proportion of COVID-19 cases have persistent chemosensory impairments at 3 to 7 months after their infection but the majority of those who had completely lost their olfactory, gustatory, and trigeminal sensitivity have improved.</p>
</abstract>
<kwd-group kwd-group-type="author">
<title>Keywords</title>
<kwd>COVID-19</kwd>
<kwd>anosmia</kwd>
<kwd>parosmia</kwd>
<kwd>long-term</kwd>
<kwd>taste</kwd>
<kwd>trigeminal system</kwd>
</kwd-group>
<counts>
<page-count count="29"/>
</counts>
</article-meta>
<notes>
<notes notes-type="competing-interest-statement">
<title>Competing Interest Statement</title><p>The authors have declared no competing interest.</p></notes>
<notes notes-type="financial-disclosure">
<title>Funding Statement</title><p>This work was supported financially by Fonds de recherche du Quebec - Sante (chercheur boursier junior 2 #283144 to JF).</p></notes>
<notes notes-type="disclosures">
<title>Author Declarations</title><p>I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.</p><p>Yes</p><p>The details of the IRB/oversight body that provided approval or exemption for the research described are given below:</p><p>This study was reviewed and approved by the research ethics board of the CHU de Quebec - Universite Laval (MP-20-2021-5228) and all protocols were reviewed by an independent Scientific Review Committee.</p><p>All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.</p><p>Yes</p><p>I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).</p><p>Yes</p><p>I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.</p><p>Yes</p></notes>
</notes>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Coronavirus disease-2019 (COVID-19) is an ongoing major public health challenge. Olfactory dysfunction (OD) is a specific symptom that may affect approximately 60% of patients suffering from COVID-19<sup><xref ref-type="bibr" rid="c1">1</xref>-<xref ref-type="bibr" rid="c3">3</xref></sup>, and is now considered as a stronger indicator of COVID-19 than fever, cough and shortness of breath<sup><xref ref-type="bibr" rid="c4">4</xref></sup>.</p>
<p>Investigation of the long-term effects of COVID-19 on chemosensory function is hindered by the recent onset of the pandemic and other challenges: First, many studies include a relatively small number of participants<sup><xref ref-type="bibr" rid="c5">5</xref>, <xref ref-type="bibr" rid="c6">6</xref></sup> or participants with severe forms of COVID-19<sup><xref ref-type="bibr" rid="c7">7</xref>, <xref ref-type="bibr" rid="c8">8</xref></sup>. Secondly, many studies include participants with an unclear diagnosis of COVID-19, and/or self-diagnosis <sup><xref ref-type="bibr" rid="c9">9</xref>, <xref ref-type="bibr" rid="c10">10</xref></sup>. Lastly, while individuals with anosmia can usually evaluate their olfactory function with accuracy<sup><xref ref-type="bibr" rid="c11">11</xref></sup>, this self-assessment is often challenging for individuals with intermediate forms of OD (e.g., hyposmia)<sup><xref ref-type="bibr" rid="c12">12</xref></sup>.</p>
<p>OD can be quantitative or qualitative. Quantitative OD defines a reduction of olfactory sensitivity which can be either a complete (<italic>anosmia</italic>) or a partial (<italic>hyposmia</italic>) loss of olfactory function<sup><xref ref-type="bibr" rid="c13">13</xref></sup>. Qualitative OD describes an altered perception of olfactory stimuli, such as <italic>parosmia</italic>, the perception of qualitatively altered smells, or <italic>phantosmia</italic>, the perception of a smell in the absence of an objective odorant<sup><xref ref-type="bibr" rid="c13">13</xref>, <xref ref-type="bibr" rid="c14">14</xref></sup>. Overall, the prevalence of OD in the general population is around 20% <sup><xref ref-type="bibr" rid="c15">15</xref>, <xref ref-type="bibr" rid="c16">16</xref></sup>, and all different forms of OD are associated with reduced quality of life and increased risk of depression and anxiety<sup><xref ref-type="bibr" rid="c17">17</xref></sup>. In addition to OD, COVID-19 also appears to affect other chemosensory functions, i.e. gustatory and trigeminal perception <sup><xref ref-type="bibr" rid="c9">9</xref>, <xref ref-type="bibr" rid="c18">18</xref></sup>.</p>
<p>To comprehensively understand long-term olfactory, gustatory, and trigeminal alterations after COVID-19, we analyzed questionnaire responses from a cohort of healthcare workers infected with SARS-CoV-2 during the first wave of the pandemic (February -June 2020). We also developed a Chemosensory Perception Test (CPT), a formal test employing common household odorants and tastants, to enable accessible yet accurate self-evaluation of chemosensory functions.</p>
</sec>
<sec id="s2">
<title>Materials and Methods</title>
<sec id="s2a">
<title>Participants</title>
<p>Participants were recruited from a Quebec healthcare worker cohort who have had SARS-CoV-2 infection between 28/2/2020 and 14/6/2020. They were part of a study from the Institut National de Sant&#x00E9; Publique du Qu&#x00E9;bec and had agreed to be contacted for other research projects<sup><xref ref-type="bibr" rid="c19">19</xref></sup>. Inclusion criteria were (1) RT-PCR confirmed COVID-19 (2) above 18 years of age, (3) French or English speakers, (4) completed the online questionnaire, and (5) did not report of other respiratory diseases (bacterial or viral infection, or/and allergies with rhinorrhea) within 2 weeks prior to questionnaire completion or chronic sinusitis (<xref rid="fig1" ref-type="fig">Figure 1</xref>).</p>
<fig id="fig1" position="float" fig-type="figure">
<label>Figure 1.</label>
<caption><title>Flowchart of participant inclusion/exclusion procedures.</title>
<p>Flowchart of the study design. INSPQ: Institut national de sant&#x00E9; publique.</p></caption>
<graphic xlink:href="21259639v2_fig1.tif"/>
</fig>
<p>This study was reviewed and approved by the research ethics board of the CHU de Qu&#x00E9;bec &#x2013; Universit&#x00E9; Laval (MP-20-2021-5228) and all protocols were reviewed by an independent Scientific Review Committee. This study also complies with the Declaration of Helsinki for Medical Research Involving Human Subjects. All participants provided an online informed consent prior to participation. The study received funding from the Fonds de recherche du Qu&#x00E9;bec-Sant&#x00E9;. No compensation or incentive was offered for participation. Data were collected from August 11 to October 29, 2020. Up to four attempts were made to reach by email potential participants. At the time of data collection, participants were 3-7 months after the onset of COVID-19 symptoms.</p>
</sec>
<sec id="s2b">
<title>Online questionnaire</title>
<p>All participants were asked to complete an online questionnaire which was adapted from the core questionnaire of the Global Consortium on Chemosensory Research<sup><xref ref-type="bibr" rid="c9">9</xref></sup>.</p>
<sec id="s2b1">
<title>Demographic information</title>
<p>In the first part of the questionnaire, demographic information was collected from all participants. Participants were then instructed to provide medical history and indicate the presence of specific COVID-19 symptoms (<xref rid="fig2" ref-type="fig">Figure 2</xref>).</p>
<fig id="fig2" position="float" fig-type="figure">
<label>Figure 2.</label>
<caption><title>Web-based interface and structure of the online questionnaire.</title>
<p>Left, Self-rating of olfaction and reporting of CPT using VAS through the web-based interface, as viewed by the participant. Right, Sections of the online questionnaire. VAS: visual analog scale.</p></caption>
<graphic xlink:href="21259639v2_fig2.tif"/>
</fig>
</sec>
<sec id="s2b2">
<title>Chemosensory self-assessment</title>
<p>Participants were asked to self-evaluate and report their olfactory, gustatory, and trigeminal sensitivity using a 10-point visual analog scale (VAS; <xref rid="fig2" ref-type="fig">Figure 2</xref>) for three timepoints: (1) before SARS-CoV-2 infection, (2) during SARS-CoV-2 infection and (3) at questionnaire completion. Further, information on the presence of parosmia or phantosmia following the infection<sup><xref ref-type="bibr" rid="c20">20</xref></sup> and alterations in the 5 tastes (sweet, salty, sour, bitter, umami) was collected.</p>
</sec>
<sec id="s2b3">
<title>Chemosensory Perception Test (CPT)</title>
<p>Items commonly found in North American households were used to assess participants&#x2019; olfactory and gustatory functions, as odor intensity is the best single predictor to classify individuals with normosmia<sup><xref ref-type="bibr" rid="c21">21</xref></sup>. Participants had to smell three substances (peanut butter, jam/jelly, and coffee) and rate odor intensity on a 10-point VAS (0: no smell at all; 10: very strong smell). We obtained olfactory scores by averaging these ratings. Pilot data on a total of 93 participants show these scores to accurately detect OD when compared to the Sniffin&#x2019; Sticks (cut-off score: 6/10; sensitivity: 0.765; specificity: 0.895; Supplement 3). Participants were asked to prepare saline and sweet water by dissolving respectively a teaspoon of salt or 3 teaspoons of sugar in a cup (250 mL) of lukewarm water. Then, they were asked to taste saline and sweet water and to rate taste intensities on a 10-point VAS. We obtained gustatory scores by averaging these ratings.</p>
</sec>
</sec>
<sec id="s2c">
<title>Statistical Analyses</title>
<p>A Python script (Python 3.7.5, Python Software Foundation, <ext-link ext-link-type="uri" xlink:href="https://www.python.org">https://www.python.org</ext-link>) was used to process raw questionnaire data and to calculate the number of participants reporting COVID-19 symptoms, chronic conditions and recent respiratory illnesses. Processed data were analyzed and visualized with SPSS 26.0 (Armonk, NY: IBM Corp), GraphPad Prism 8.3.1 (GraphPad Prism Software, San Diego, CA) and Raincloud plots<sup><xref ref-type="bibr" rid="c22">22</xref></sup>.</p>
<p>Parametric (ANOVA) or non-parametric (Friedman) tests were chosen depending on whether normality assumption was fulfilled. To evaluate the effects of COVID-19 on <italic>modality</italic> (olfactory, gustatory, and trigeminal) and <italic>time</italic> (prior to, during and after COVID-19 infection), for <italic>gender</italic> (women, men), repeated measures (rm) ANOVA with age as a covariate were computed. To disentangle interactions, separate rmANOVA were carried out for individual modalities and timepoints with the same factors. Greenhouse-Geisser corrections were used for sphericity and Tukey&#x2019;s multiple comparisons test were used for post-hoc comparisons. Friedman&#x2019;s test was followed by Dunn&#x2019;s post-hoc test to correct for multiple comparisons. To assess the correlation between self-reported olfactory, gustatory, and trigeminal abilities and results of the CPT, Pearson correlation coefficient or Spearman&#x2019;s rank correlation coefficient was used. For all statistical tests, alpha was set at 0.05. All results are expressed as mean (SD) unless otherwise specified.</p>
</sec>
</sec>
<sec id="s3">
<title>Results</title>
<sec id="s3a">
<title>Characteristics of participants</title>
<p>A total of 704 healthcare workers (593 (84.2%) women, mean age of 42.0 (SD:11.7, range 18 &#x2013; 70) years were included. The questionnaire was completed on average 4.8 (SD: 0.8, range 3-7) months after symptoms onset. COVID-19 symptoms reported by the 704 participants are listed in <xref rid="tbl1" ref-type="table">Table 1</xref>.</p>
<table-wrap id="tbl1" orientation="portrait" position="float">
<label>Table 1.</label>
<caption><p>COVID-19 symptoms of the 704 participants.</p></caption>
<graphic xlink:href="21259639v2_tbl1.tif"/>
</table-wrap>
</sec>
<sec id="s3b">
<title>Quantitative disorders</title>
<p>Before COVID-19, average self-reported score was 9.0 (1.6), 9.2 (1.3) and 8.9 (1.9) of 10 for olfaction, gustation and trigeminal function, respectively. Among participants, 0.9%, 0.7% and 1.8% respectively reported an absence of olfaction, gustation and trigeminal function (score 0; <xref rid="fig3" ref-type="fig">Figure 3</xref>). During COVID-19, average self-reported score was 2.6 (3.6) for olfaction, 3.4 (3.6) for gustation, and 7.0 (3.0) for trigeminal sensitivity. In the 704 participants, 51.1%, 33.5% and 5.7% reported absence of olfaction, gustation and trigeminal function. At time of questionnaire completion, mean scores were 7.4 (2.5), 8.0 (2.2) and 8.5 (2.2) for olfaction, gustation and trigeminal function respectively and absence of chemical senses was reported respectively by 1.4%, 0.7% and 2.3%.</p>
<fig id="fig3" position="float" fig-type="figure">
<label>Figure 3.</label>
<caption><title>Self-reported scores for the chemosensory modalities before, during and after COVID-19 infection (n=704).</title>
<p>Raincloud plot representing self-reported scores for olfaction, gustation, and trigeminal function before, during and after COVID-19. Ratings from individual participants are displayed as dots. Boxplots show the first to third quartiles, horizontal line denotes the median, and whiskers denote 1.5 times interquartile range. Compared to baseline, self-reported scores of olfaction, gustation and trigeminal function were significantly lower during COVID-19 and have not fully returned to baseline values 5 months after COVID-19.</p></caption>
<graphic xlink:href="21259639v2_fig3.tif"/>
</fig>
<p>Compared to the baseline chemosensory functions before COVID-19, 572 (81.3%), 574 (81.5) and 338 (48.0%) reported lower olfactory, gustatory, and trigeminal sensitivity during COVID-19. Olfactory and gustatory dysfunction were present in similar proportions (&#x03C7;<sup>2</sup>(2, N=704) =0.02, <italic>P</italic>=.891) and were different to trigeminal (olfaction: &#x03C7;<sup>2</sup>(2, N=704) = 174.81 <italic>P</italic>&#x003C;.001; gustation: &#x03C7;<sup>2</sup>(2, N=704) = 174.56 <italic>P</italic>&#x003C;.001). Three to seven months after the infection, 366 (52.0%), 295 (41.9%), 164 (23.3%) reported lower olfactory, gustatory, and trigeminal sensitivity compared to before COVID-19 (<xref rid="tbl2" ref-type="table">Table 2</xref>). These proportions were significantly different between all three chemosensory systems (&#x03C7;<sup>2</sup>(2, N=704) = 123.46, <italic>P</italic>&#x003C;.001).</p>
<table-wrap id="tbl2" orientation="portrait" position="float">
<label>Table 2.</label>
<caption><p>Self-reported chemosensory alterations by age group and gender during and 3 to 7 months following COVID-19 (n=704).</p></caption>
<graphic xlink:href="21259639v2_tbl2.tif"/>
</table-wrap>
<p>Overall, there were significant effects of <italic>modality</italic> (F(2,1402)=42.83,<italic>P</italic>&#x003C;.001,<inline-formula><alternatives><inline-graphic xlink:href="21259639v2_inline1.gif"/></alternatives></inline-formula>; olfactory&#x003C;gustatory&#x003C;trigeminal; all <italic>P</italic>&#x003C;.001), <italic>time</italic> (F(2,1402)=118.47, <italic>P</italic>&#x003C;.001, <inline-formula><alternatives><inline-graphic xlink:href="21259639v2_inline2.gif"/></alternatives></inline-formula>; during&#x003C;after&#x003C;before; all <italic>P</italic>&#x003C;.001), and <italic>gender</italic> (F(1,701)=5.52, <italic>P</italic>=0.019, <inline-formula><alternatives><inline-graphic xlink:href="21259639v2_inline3.gif"/></alternatives></inline-formula>; women&#x003C;men) and significant interactions between these factors (<italic>modality&#x002A;time, modality&#x002A;time&#x002A;gender</italic>; all <italic>P</italic>&#x003C;.001) on chemosensory self-evaluation. To disentangle these interactions, we analyzed data separately per chemosensory modality and time points.</p>
<sec id="s3b1">
<title>Chemosensory modality</title>
<p>With regards to <underline>olfactory</underline> function, significant main effects of <italic>time</italic> (F(2,1402)=165.07, <italic>P</italic>&#x003C;.001 <inline-formula><alternatives><inline-graphic xlink:href="21259639v2_inline4.gif"/></alternatives></inline-formula>; during&#x003C;after&#x003C;before; all <italic>P</italic>&#x003C;.001; <xref rid="fig3" ref-type="fig">Figure 3A</xref>), <italic>age</italic> (F(1,701)=4.42, <italic>P</italic>=.012, <inline-formula><alternatives><inline-graphic xlink:href="21259639v2_inline5.gif"/></alternatives></inline-formula>) and <italic>gender</italic> (F(1,701)=4.42, P=.036, <inline-formula><alternatives><inline-graphic xlink:href="21259639v2_inline6.gif"/></alternatives></inline-formula>; women &#x003C; men) were revealed. In addition, we observed significant interactions of <italic>time&#x002A;age</italic> (F(2,1402)=23.39, <italic>P</italic>&#x003C;.001, <inline-formula><alternatives><inline-graphic xlink:href="21259639v2_inline7.gif"/></alternatives></inline-formula>) and <italic>time&#x002A;gender</italic> (F(2, 1402)=21.69, <italic>P</italic>&#x003C;0.001, <inline-formula><alternatives><inline-graphic xlink:href="21259639v2_inline8.gif"/></alternatives></inline-formula>).</p>
<p>With regards to gustatory function, we observed significant main effects of <italic>time</italic> (F(2,1402)=102.97, <italic>P</italic>&#x003C;.001, <inline-formula><alternatives><inline-graphic xlink:href="21259639v2_inline9.gif"/></alternatives></inline-formula>; during&#x003C;after&#x003C;before; all <italic>P</italic>&#x003C;.001; <xref rid="fig3" ref-type="fig">Figure 3B</xref>) and <italic>gender</italic> (F(1, 701)=9.80, <italic>P</italic>=.002, <inline-formula><alternatives><inline-graphic xlink:href="21259639v2_inline10.gif"/></alternatives></inline-formula>; women&#x003C;men), but no effect of <italic>age</italic>. We also observed significant interactions of <italic>time&#x002A;age</italic> (F(2, 1402))=5.97, <italic>P</italic>=.005, <inline-formula><alternatives><inline-graphic xlink:href="21259639v2_inline11.gif"/></alternatives></inline-formula>) and <italic>time&#x002A;gender</italic> (F(2, 1402))=20.02, <italic>P</italic>&#x003C;.001, <inline-formula><alternatives><inline-graphic xlink:href="21259639v2_inline12.gif"/></alternatives></inline-formula>).</p>
<p>With regards to <underline>trigeminal</underline> function, we observed significant main effects of <italic>time</italic> (F(2,1402)=3.91, <italic>P</italic>=.020, <inline-formula><alternatives><inline-graphic xlink:href="21259639v2_inline13.gif"/></alternatives></inline-formula>; during&#x003C;after&#x003C;before; all <italic>P</italic>&#x003C;.001; <xref rid="fig3" ref-type="fig">Figure 3C</xref>), and age ((1,701)=5.08, <italic>P</italic>=.025, <inline-formula><alternatives><inline-graphic xlink:href="21259639v2_inline14.gif"/></alternatives></inline-formula>) but no effect of <italic>gender</italic>. We also identified significant interactions of <italic>time&#x002A;age</italic> (F(2, 1402)=4.70, <italic>P</italic>=.016, <inline-formula><alternatives><inline-graphic xlink:href="21259639v2_inline15.gif"/></alternatives></inline-formula>) and <italic>time&#x002A;gender</italic> (F(2, 1402)=4.50, <italic>P</italic>=.019, <inline-formula><alternatives><inline-graphic xlink:href="21259639v2_inline16.gif"/></alternatives></inline-formula>).</p>
</sec>
<sec id="s3b2">
<title>Time point</title>
<p>With regards to chemosensory function before infection, we observed a significant effect of <italic>gender</italic> (F(1,701)=8.52, <italic>P</italic>=.004, <inline-formula><alternatives><inline-graphic xlink:href="21259639v2_inline17.gif"/></alternatives></inline-formula>; men &#x003C; women), but not of <italic>modality, age</italic> nor interactions. <underline>During</underline> COVID-19, we observed a significant effects of <italic>modality</italic> (F(2, 1402)=96.714, <italic>P</italic>&#x003C;.001, <inline-formula><alternatives><inline-graphic xlink:href="21259639v2_inline18.gif"/></alternatives></inline-formula>; olfaction&#x003C;gustation&#x003C;trigeminal; all <italic>P</italic>&#x003C;.001), <italic>gender</italic> (F(1, 701)=21.98, <italic>P</italic>&#x003C;.001, <inline-formula><alternatives><inline-graphic xlink:href="21259639v2_inline19.gif"/></alternatives></inline-formula>; women&#x003C;men), and age (F(1, 701)=4.74, <italic>P</italic>=.030, <inline-formula><alternatives><inline-graphic xlink:href="21259639v2_inline20.gif"/></alternatives></inline-formula>). Further, we found significant interactions <italic>modality</italic>&#x002A;<italic>age</italic> (F(2, 1402)=24.185, <italic>P</italic>&#x003C;.001, <inline-formula><alternatives><inline-graphic xlink:href="21259639v2_inline21.gif"/></alternatives></inline-formula>) and <italic>modality&#x002A;gender</italic> (F(2, 1402)=6.76, <italic>P</italic>=.002, <inline-formula><alternatives><inline-graphic xlink:href="21259639v2_inline22.gif"/></alternatives></inline-formula>). Finally, after infection, we observed a significant effect of <italic>modality</italic> (F(2, 1402)=9.91, <italic>P</italic>&#x003C;.001, <inline-formula><alternatives><inline-graphic xlink:href="21259639v2_inline23.gif"/></alternatives></inline-formula>; olfaction&#x003C;gustation&#x003C;trigeminal; all <italic>P</italic>&#x003C;.015), but not of <italic>gender</italic> or <italic>age</italic>, nor any interaction.</p>
<p>Compared to baseline (before infection), changes in chemosensory function were correlated for all modalities during infection (olfaction-gustation: &#x03C1;=0.69; gustation-trigeminal: &#x03C1;=0.43; olfaction-trigeminal: &#x03C1;=0.33; all <italic>P</italic>&#x003C;.001, <xref rid="fig4" ref-type="fig">Figure 4 A-C</xref>) and after infection (olfaction-gustation: &#x03C1;=0.69; gustation-trigeminal: &#x03C1;=0.40; olfaction-trigeminal: &#x03C1;=0.36; all <italic>P</italic>&#x003C;.001, <xref rid="fig4" ref-type="fig">Figure 4 D-F</xref>).</p>
<fig id="fig4" position="float" fig-type="figure">
<label>Figure 4.</label>
<caption><title>Correlations between alterations in chemosensory modalities (n=704).</title>
<p>Red squares, correlations between alterations in olfaction, gustation, and trigeminal functions during COVID-19. Grey hexagons, correlations between alterations in olfaction, gustation, and trigeminal functions after COVID-19. Darker colors indicate higher occurrence.</p></caption>
<graphic xlink:href="21259639v2_fig4.tif"/>
</fig>
</sec>
</sec>
<sec id="s3c">
<title>Qualitative disorders</title>
<p>Among included participants, 78 (11.1%) reported parosmia, 73 (10.4%) experienced phantosmia and/or 82 (11.6%) had waxing and waning of olfaction following infection. In addition, 42 (6.0%) claimed that they experienced other forms of OD (hyposmia to specific substances, hyperosmia, parosmia only at high concentrations or slow identification times). Furthermore, 335 (47.6%) participants reported changes to perception of sweet, 338 (48.0%) salty, 293 (41.6%) sour, 309 (43.9%) bitter and 281 (39.9%) umami. A total of 275 (39.1%) participants reported alterations in all 5 tastes.</p>
</sec>
<sec id="s3d">
<title>Chemosensory Perception Test</title>
<p>Among the 704 participants, 137 (19.5%) had a CPT score suggestive of OD. Mean CPT scores were lower for olfaction than gustation (7.84 (1.78) vs 8.42 (2.31); Z=8.193, <italic>P</italic>&#x003C;.001). Neither <italic>age</italic> nor <italic>gender</italic> had an effect on CPT scores. CPT scores correlated with self-reported chemosensory abilities at testing time (olfaction: &#x03C1;=0.67; gustation: &#x03C1;=0.51; <italic>P</italic>&#x003C;.001 for both).</p>
</sec>
</sec>
<sec id="s4">
<title>Discussion</title>
<p>This study reports chemosensory dysfunction 3 to 7 months following SARS-CoV-2 infection in a large cohort of RT-PCR-confirmed healthcare workers. In addition to confirming the now well-established detrimental effect of acute COVID-19 on all three chemosensory systems (olfactory, gustatory, trigeminal), our major findings are: (1) the detrimental effect of COVID-19 lasts beyond the acute phase after the infection, half of those affected indicated that olfactory function had not returned to the baseline levels 3 to 7 months later, while 20% of infected participants reported scores in a formal test that are consistent with the presentation of hyposmia/anosmia; (2) approximately 10% of the patients exhibit parosmia and/or phantosmia; (3) women are more heavily affected than men.</p>
<p>We observed chemosensory dysfunction in the acute phase of COVID-19, which was most pronounced for olfactory function, but less so for gustatory function and even less for trigeminal function. The proportion of participants describing OD and GD in the acute phase of COVID-19 in this study was comparable to earlier studies<sup><xref ref-type="bibr" rid="c23">23</xref></sup>. Nevertheless, on average 4.8 months after infection and thus well after the acute phase, approximately 50% and 40% of patients reported persistent alterations in olfactory and gustatory sensitivity, respectively; these numbers are higher than what has been reported<sup><xref ref-type="bibr" rid="c24">24</xref>, <xref ref-type="bibr" rid="c25">25</xref></sup>.</p>
<p>We found a moderate-to-strong correlation between self-reported olfactory and gustatory changes, which were stronger than with self-reported trigeminal changes. This could be due to similar pathophysiological alterations in the olfactory and gustatory systems and their differences from that of the trigeminal system. Knowing that the general population often mixes up retro-olfaction (perceiving odors from the substances in the mouth traveling posteriorly and rostrally to the olfactory epithelium) with taste, an alternative explanation would be a misunderstanding of this nuance by participants despite the fact that specific definitions for each modality were given<sup><xref ref-type="bibr" rid="c26">26</xref> <xref ref-type="bibr" rid="c27">27</xref></sup>. The latter hypothesis is more probable since the correlation between gustatory self-report and CPT gustatory scores using strict gustatory stimuli (salt, sugar) is lower than the correlation between olfactory self-report and CPT olfactory scores.</p>
<p>Moreover, approximately 10% reported parosmia and/or phantosmia following SARS-CoV-2 infection. These qualitative smell disorders usually involve unpleasant olfactory sensations (rotten eggs, sewage, smoke). While the exact patho-mechanism of parosmia and phantosmia are still to be elucidated, parosmia is probably linked to altered peripheral input/central processing of olfactory stimuli<sup><xref ref-type="bibr" rid="c28">28</xref></sup>. Importantly, patients with postviral OD and parosmia exhibit better recovery rates following olfactory training than those without parosmia<sup><xref ref-type="bibr" rid="c29">29</xref></sup>. Follow-ups will determine to what extent parosmia predicts a better outcome.</p>
<p>Women&#x2019;s chemical senses were more affected than men by the infection. Women typically have better scores in olfactory testing than men <sup><xref ref-type="bibr" rid="c30">30</xref></sup>. In turn, women exhibit a higher prevalence and a longer persistence of postviral OD<sup><xref ref-type="bibr" rid="c31">31</xref>, <xref ref-type="bibr" rid="c32">32</xref></sup>, in line with our results. Gender differences could be explained by a multitude of neuroendocrine, social, and cognitive factors<sup><xref ref-type="bibr" rid="c31">31</xref></sup>. This suggests that the burden of COVID-19-related OD is more important for women than for men.</p>
<p>Different theories have been proposed to explain the persistence of OD in certain individuals, ranging from olfactory epithelium dysfunction to central nervous system infection <sup><xref ref-type="bibr" rid="c33">33</xref>-<xref ref-type="bibr" rid="c35">35</xref></sup>. Since cells of the olfactory epithelium possess the ability to regenerate, the re-establishment of olfactory function is possible in the context of postinfectious OD <sup><xref ref-type="bibr" rid="c36">36</xref></sup>, as well as in COVID-19-related OD, where 75-85% of the affected individuals recovered olfactory function within 60 days <sup><xref ref-type="bibr" rid="c24">24</xref>, <xref ref-type="bibr" rid="c37">37</xref></sup>. In addition to OD and GD, TD has also been reported in patients with COVID-19 <sup><xref ref-type="bibr" rid="c9">9</xref>, <xref ref-type="bibr" rid="c18">18</xref></sup>. Our study indicates chemosensory dysfunction in 18.9% of participants as measured by the CPT 3 to 7 months after infection.</p>
<p>Persistent chemosensory dysfunctions may be a sign of chronic central nervous system alterations<sup><xref ref-type="bibr" rid="c38">38</xref>, <xref ref-type="bibr" rid="c39">39</xref></sup>, and there is now evidence that SARS-CoV-2 can infect olfactory sensory neurons in humans<sup><xref ref-type="bibr" rid="c40">40</xref></sup>. Other viruses, such as the Japanese encephalitis virus, Varicella-Zoster virus, measles virus, human immunodeficiency virus and CoVs, were shown to invade the CNS<sup><xref ref-type="bibr" rid="c41">41</xref></sup>. Febrile seizures, loss of consciousness, convulsions, ataxia, status epilepticus, encephalitis, myelitis, neuritis and extrapyramidal symptoms are among extra-pulmonary symptoms that have been described<sup><xref ref-type="bibr" rid="c42">42</xref></sup>. The persistence of postinfectious neurological symptoms may contribute to the development or aggravation of chronic neurological diseases such as Parkinson, multiple sclerosis, or psychiatric outcomes<sup><xref ref-type="bibr" rid="c41">41</xref>, <xref ref-type="bibr" rid="c43">43</xref>-<xref ref-type="bibr" rid="c51">51</xref></sup>. These patients should be followed up to document the development of neurological sequalae.</p>
<p>Olfactory and other chemosensory dysfunctions may have detrimental effects. First, affected individuals can expose themselves to harmful substances such as smoke, gas or spoiled food<sup><xref ref-type="bibr" rid="c52">52</xref>, <xref ref-type="bibr" rid="c53">53</xref></sup>. It may trigger dysfunctional nutritional patterns like increased salt and sugar consumption and anorexia<sup><xref ref-type="bibr" rid="c54">54</xref>, <xref ref-type="bibr" rid="c55">55</xref></sup>. Individuals with OD also have higher rates of anxiety and depression<sup><xref ref-type="bibr" rid="c17">17</xref>, <xref ref-type="bibr" rid="c56">56</xref></sup>. Moreover, a functioning olfactory system may be a necessity in some workplaces such as in healthcare, where staff are required to have the ability to detect and qualify the smell of urine, excrement, infected wounds or abnormal smells of breath<sup><xref ref-type="bibr" rid="c57">57</xref></sup>. Currently, there is no approved therapy for COVID-19-induced OD, although olfactory training has a significant effect on olfactory function according to studies on other viral infections<sup><xref ref-type="bibr" rid="c58">58</xref>-<xref ref-type="bibr" rid="c60">60</xref></sup>. Most importantly, long-term follow-up of these patients will be necessary to assess other signs of neurological damage.</p>
<sec id="s4a">
<title>Limitations</title>
<p>Given the cross-sectional design of the study, a recall bias is possible for all self-reported peri-SARS-CoV-2 infection values before or during the SARS-CoV-2 infection due to the 3-to-7-month gap. This study did not control for potential confounding factors like race and level of education. Finally, the CPT requires further validation for its gustatory and trigeminal components, and it relies on substances found in participants&#x2019; homes, which may lead to variation in test results due to the differences in the brand, quality, or expiration date of substances and consequently, their ability to trigger equal sensorineural responses.</p>
</sec>
</sec>
<sec id="s5">
<title>Conclusions</title>
<p>Nearly two thirds of SARS-CoV-2 infected patients had chemosensory impairments during their infection and despite improvements, impairments persist in more than half of them 3 to 7 months after COVID-19. Quantitative and qualitative olfactory dysfunction as well as persisting gustatory and trigeminal deficits were common in the cohort presented in this study. Given the frequency of these problems and the possible neurological underpinnings of these observations, it will be critical to understand the underlying mechanisms of these chemosensory dysfunctions, their evolution, and possible therapeutic options.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability">
<title>Data Availability</title>
<p>Data can be made available upon request.</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>We thank Josiane Rivard for preparing the online questionnaire, C&#x00E9;cilia Tremblay, &#x00C9;milie Aubry-Lafontaine and Fr&#x00E9;d&#x00E9;rique Roy-C&#x00F4;t&#x00E9; for data collection and the validation of the Chemosensory Perception Test, and all study participants and frontline healthcare workers facing the COVID-19 pandemic. This work was supported by Fonds de recherche du Qu&#x00E9;bec &#x2013; Sant&#x00E9; (chercheur boursier junior 2 #283144 to JF). NB and JF had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. FGL is the recipient of a tier-2 Canada research Chair. All authors declare no conflict of interest.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="c1"><label>1.</label><mixed-citation publication-type="journal"><string-name><surname>Spinato</surname> <given-names>G</given-names></string-name>, <string-name><surname>Fabbris</surname> <given-names>C</given-names></string-name>, <string-name><surname>Polesel</surname> <given-names>J</given-names></string-name>, <string-name><surname>Cazzador</surname> <given-names>D</given-names></string-name>, <string-name><surname>Borsetto</surname> <given-names>D</given-names></string-name>, <string-name><surname>Hopkins</surname> <given-names>C</given-names></string-name>, <etal>et al.</etal> <article-title>Alterations in Smell or Taste in Mildly Symptomatic Outpatients With SARS-CoV-2 Infection</article-title>. <source>JAMA</source>. <year>2020</year>;<volume>323</volume> (<issue>20</issue>):<fpage>2089</fpage>&#x2013;<lpage>2090</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jama.2020.6771</pub-id> %J JAMA</mixed-citation></ref>
<ref id="c2"><label>2.</label><mixed-citation publication-type="journal"><string-name><surname>Whitcroft</surname> <given-names>KL</given-names></string-name>, <string-name><surname>Hummel</surname> <given-names>T.</given-names></string-name> <article-title>Olfactory Dysfunction in COVID-19: Diagnosis and Management</article-title>. <source>JAMA</source>. <year>2020</year>;<volume>323</volume> (<issue>24</issue>):<fpage>2512</fpage>&#x2013;<lpage>2514</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jama.2020.8391</pub-id> %J JAMA</mixed-citation></ref>
<ref id="c3"><label>3.</label><mixed-citation publication-type="journal"><string-name><surname>von Bartheld</surname> <given-names>CS</given-names></string-name>, <string-name><surname>Hagen</surname> <given-names>MM</given-names></string-name>, <string-name><surname>Butowt</surname> <given-names>R.</given-names></string-name> <article-title>Prevalence of Chemosensory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis Reveals Significant Ethnic Differences</article-title>. <source>ACS Chem Neurosci</source>. <month>Oct</month> 7 <year>2020</year>;<volume>11</volume>(<issue>19</issue>):<fpage>2944</fpage>&#x2013;<lpage>2961</lpage>. doi:<pub-id pub-id-type="doi">10.1021/acschemneuro.0c00460</pub-id></mixed-citation></ref>
<ref id="c4"><label>4.</label><mixed-citation publication-type="journal"><string-name><surname>Gerkin</surname> <given-names>R</given-names></string-name>, <string-name><surname>Ohla</surname> <given-names>K</given-names></string-name>, <string-name><surname>Veldhuizen</surname> <given-names>M</given-names></string-name>, <string-name><surname>Joseph</surname> <given-names>P</given-names></string-name>, <string-name><surname>Kelly</surname> <given-names>C</given-names></string-name>, <string-name><surname>Bakke</surname> <given-names>A</given-names></string-name>, <etal>et al.</etal> <article-title>Recent Smell Loss Is the Best Predictor of COVID-19 Among Individuals With Recent Respiratory Symptoms</article-title>. <source>Chemical Senses.x02/01</source> <year>2021</year>;<volume>46</volume></mixed-citation></ref>
<ref id="c5"><label>5.</label><mixed-citation publication-type="other"><string-name><surname>Le Bon</surname> <given-names>S-D</given-names></string-name>, <string-name><surname>Pisarski</surname> <given-names>N</given-names></string-name>, <string-name><surname>Verbeke</surname> <given-names>J</given-names></string-name>, <string-name><surname>Prunier</surname> <given-names>L</given-names></string-name>, <string-name><surname>Cavelier</surname> <given-names>G</given-names></string-name>, <string-name><surname>Thill</surname> <given-names>M-P</given-names></string-name>, <etal>et al.</etal> <article-title>Psychophysical evaluation of chemosensory functions 5 weeks after olfactory loss due to COVID-19: a prospective cohort study on 72 patients</article-title>. <source>Eur Arch Otorhinolaryngol</source>. <year>2020</year>;doi:<pub-id pub-id-type="doi">10.1007/s00405-020-06267-2</pub-id></mixed-citation></ref>
<ref id="c6"><label>6.</label><mixed-citation publication-type="journal"><string-name><surname>Hintschich</surname> <given-names>CA</given-names></string-name>, <string-name><surname>Wenzel</surname> <given-names>JJ</given-names></string-name>, <string-name><surname>Hummel</surname> <given-names>T</given-names></string-name>, <string-name><surname>Hankir</surname> <given-names>MK</given-names></string-name>, <string-name><surname>K&#x00FC;hnel</surname> <given-names>T</given-names></string-name>, <string-name><surname>Vielsmeier</surname> <given-names>V</given-names></string-name>, <etal>et al.</etal> <article-title>Psychophysical tests reveal impaired olfaction but preserved gustation in COVID-19 patients</article-title>. <source>International forum of allergy &#x0026; rhinology</source>. <year>2020</year>;<volume>10</volume>(<issue>9</issue>):<fpage>1105</fpage>&#x2013;<lpage>1107</lpage>. doi:<pub-id pub-id-type="doi">10.1002/alr.22655</pub-id></mixed-citation></ref>
<ref id="c7"><label>7.</label><mixed-citation publication-type="other"><string-name><surname>Moein</surname> <given-names>ST</given-names></string-name>, <string-name><surname>Hashemian</surname> <given-names>SM</given-names></string-name>, <string-name><surname>Mansourafshar</surname> <given-names>B</given-names></string-name>, <string-name><surname>Khorram-Tousi</surname> <given-names>A</given-names></string-name>, <string-name><surname>Tabarsi</surname> <given-names>P</given-names></string-name>, <string-name><surname>Doty</surname> <given-names>RL</given-names></string-name>. <article-title>Smell dysfunction: a biomarker for COVID-19</article-title>. <source>Int Forum Allergy Rhinol</source>. <year>2020</year>;doi:<pub-id pub-id-type="doi">10.1002/alr.22587</pub-id></mixed-citation></ref>
<ref id="c8"><label>8.</label><mixed-citation publication-type="other"><string-name><surname>Speth</surname> <given-names>MM</given-names></string-name>, <string-name><surname>Singer-Cornelius</surname> <given-names>T</given-names></string-name>, <string-name><surname>Oberle</surname> <given-names>M</given-names></string-name>, <string-name><surname>Gengler</surname> <given-names>I</given-names></string-name>, <string-name><surname>Brockmeier</surname> <given-names>SJ</given-names></string-name>, <string-name><surname>Sedaghat</surname> <given-names>AR</given-names></string-name>. <article-title>Olfactory Dysfunction and Sinonasal Symptomatology in COVID-19: Prevalence, Severity, Timing, and Associated Characteristics</article-title>. <source>Otolaryngol Head Neck Surg</source>. <year>2020</year>;doi:<pub-id pub-id-type="doi">10.1177/0194599820929185</pub-id></mixed-citation></ref>
<ref id="c9"><label>9.</label><mixed-citation publication-type="other"><string-name><surname>Parma</surname> <given-names>V</given-names></string-name>, <string-name><surname>Ohla</surname> <given-names>K</given-names></string-name>, <string-name><surname>Veldhuizen</surname> <given-names>MG</given-names></string-name>, <string-name><surname>Niv</surname> <given-names>MY</given-names></string-name>, <string-name><surname>Kelly</surname> <given-names>CE</given-names></string-name>, <string-name><surname>Bakke</surname> <given-names>AJ</given-names></string-name>, <etal>et al.</etal> <article-title>More than smell. COVID-19 is associated with severe impairment of smell, taste, and chemesthesis</article-title>. <source>medRxiv</source>. <year>2020</year>:2020.05.04.20090902. doi:<pub-id pub-id-type="doi">10.1101/2020.05.04.20090902</pub-id></mixed-citation></ref>
<ref id="c10"><label>10.</label><mixed-citation publication-type="journal"><string-name><surname>Hopkins</surname> <given-names>C</given-names></string-name>, <string-name><surname>Surda</surname> <given-names>P</given-names></string-name>, <string-name><surname>Whitehead</surname> <given-names>E</given-names></string-name>, <string-name><surname>Kumar</surname> <given-names>BN</given-names></string-name>. <article-title>Early recovery following new onset anosmia during the COVID-19 pandemic &#x2013; an observational cohort study</article-title>. <source>Journal of Otolaryngology - Head &#x0026; Neck Surgery</source>. 2020/05/04 <year>2020</year>;<volume>49</volume>(<issue>1</issue>):<fpage>26</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s40463-020-00423-8</pub-id></mixed-citation></ref>
<ref id="c11"><label>11.</label><mixed-citation publication-type="journal"><string-name><surname>L&#x00F6;tsch</surname> <given-names>J</given-names></string-name>, <string-name><surname>Hummel</surname> <given-names>T.</given-names></string-name> <article-title>Clinical Usefulness of Self-Rated Olfactory Performance-A Data Science-Based Assessment of 6000 Patients</article-title>. <source>Chem Senses</source>. <month>Jul</month> 17 <year>2019</year>;<volume>44</volume>(<issue>6</issue>):<fpage>357</fpage>&#x2013;<lpage>364</lpage>. doi:<pub-id pub-id-type="doi">10.1093/chemse/bjz029</pub-id></mixed-citation></ref>
<ref id="c12"><label>12.</label><mixed-citation publication-type="journal"><string-name><surname>Landis</surname> <given-names>BN</given-names></string-name>, <string-name><surname>Hummel</surname> <given-names>T</given-names></string-name>, <string-name><surname>Hugentobler</surname> <given-names>M</given-names></string-name>, <string-name><surname>Giger</surname> <given-names>R</given-names></string-name>, <string-name><surname>Lacroix</surname> <given-names>JS</given-names></string-name>. <article-title>Ratings of overall olfactory function</article-title>. <source>Chem Senses</source>. <month>Oct</month> <year>2003</year>;<volume>28</volume>(<issue>8</issue>):<fpage>691</fpage>&#x2013;<lpage>4</lpage>. doi:<pub-id pub-id-type="doi">10.1093/chemse/bjg061</pub-id></mixed-citation></ref>
<ref id="c13"><label>13.</label><mixed-citation publication-type="journal"><string-name><surname>Hummel</surname> <given-names>T</given-names></string-name>, <string-name><surname>Whitcroft</surname> <given-names>KL</given-names></string-name>, <string-name><surname>Andrews</surname> <given-names>P</given-names></string-name>, <string-name><surname>Altundag</surname> <given-names>A</given-names></string-name>, <string-name><surname>Cinghi</surname> <given-names>C</given-names></string-name>, <string-name><surname>Costanzo</surname> <given-names>RM</given-names></string-name>, <etal>et al.</etal> <article-title>Position paper on olfactory dysfunction</article-title>. <source>Rhinology</source>. <month>Jan</month> 31 <year>2016</year>;<volume>56</volume>(<issue>1</issue>):<fpage>1</fpage>&#x2013;<lpage>30</lpage>. doi:<pub-id pub-id-type="doi">10.4193/Rhin16.248</pub-id></mixed-citation></ref>
<ref id="c14"><label>14.</label><mixed-citation publication-type="journal"><string-name><surname>Sj&#x00F6;lund</surname> <given-names>S</given-names></string-name>, <string-name><surname>Larsson</surname> <given-names>M</given-names></string-name>, <string-name><surname>Olofsson</surname> <given-names>JK</given-names></string-name>, <string-name><surname>Seubert</surname> <given-names>J</given-names></string-name>, <string-name><surname>Laukka</surname> <given-names>EJ</given-names></string-name>. <article-title>Phantom Smells: Prevalence and Correlates in a Population-Based Sample of Older Adults</article-title>. <source>Chemical senses</source>. <year>2017</year>;<volume>42</volume>(<issue>4</issue>):<fpage>309</fpage>&#x2013;<lpage>318</lpage>. doi:<pub-id pub-id-type="doi">10.1093/chemse/bjx006</pub-id></mixed-citation></ref>
<ref id="c15"><label>15.</label><mixed-citation publication-type="journal"><string-name><surname>Yang</surname> <given-names>J</given-names></string-name>, <string-name><surname>Pinto</surname> <given-names>JM</given-names></string-name>. <article-title>The Epidemiology of Olfactory Disorders</article-title>. <source>Curr Otorhinolaryngol Rep</source>. <year>2016</year>;<volume>4</volume>(<issue>2</issue>):<fpage>130</fpage>&#x2013;<lpage>141</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s40136-016-0120-6</pub-id></mixed-citation></ref>
<ref id="c16"><label>16.</label><mixed-citation publication-type="journal"><string-name><surname>Landis</surname> <given-names>BN</given-names></string-name>, <string-name><surname>Konnerth</surname> <given-names>CG</given-names></string-name>, <string-name><surname>Hummel</surname> <given-names>T.</given-names></string-name> <article-title>A study on the frequency of olfactory dysfunction</article-title>. <source>Laryngoscope</source>. <month>Oct</month> <year>2004</year>;<volume>114</volume> (<issue>10</issue>):<fpage>1764</fpage>&#x2013;<lpage>9</lpage>. doi:<pub-id pub-id-type="doi">10.1097/00005537-200410000-00017</pub-id></mixed-citation></ref>
<ref id="c17"><label>17.</label><mixed-citation publication-type="journal"><string-name><surname>Croy</surname> <given-names>I</given-names></string-name>, <string-name><surname>Nordin</surname> <given-names>S</given-names></string-name>, <string-name><surname>Hummel</surname> <given-names>T.</given-names></string-name> <article-title>Olfactory Disorders and Quality of Life&#x2014;An Updated Review</article-title>. <source>Chemical Senses</source>. <year>2014</year>;<volume>39</volume>(<issue>3</issue>):<fpage>185</fpage>&#x2013;<lpage>194</lpage>. doi:<pub-id pub-id-type="doi">10.1093/chemse/bjt072</pub-id></mixed-citation></ref>
<ref id="c18"><label>18.</label><mixed-citation publication-type="journal"><string-name><surname>Cooper</surname> <given-names>KW</given-names></string-name>, <string-name><surname>Brann</surname> <given-names>DH</given-names></string-name>, <string-name><surname>Farruggia</surname> <given-names>MC</given-names></string-name>, <string-name><surname>Bhutani</surname> <given-names>S</given-names></string-name>, <string-name><surname>Pellegrino</surname> <given-names>R</given-names></string-name>, <string-name><surname>Tsukahara</surname> <given-names>T</given-names></string-name>, <etal>et al.</etal> <article-title>COVID-19 and the Chemical Senses: Supporting Players Take Center Stage</article-title>. <source>Neuron</source>. <year>2020</year>;<volume>107</volume> (<issue>2</issue>):<fpage>219</fpage>&#x2013;<lpage>233</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuron.2020.06.032</pub-id></mixed-citation></ref>
<ref id="c19"><label>19.</label><mixed-citation publication-type="other"><string-name><surname>Carazo</surname> <given-names>SLD</given-names></string-name>, <string-name><surname>Villeneuve</surname> <given-names>J</given-names></string-name>, <string-name><surname>Martin</surname> <given-names>R</given-names></string-name>, <string-name><surname>Deshaies</surname> <given-names>P</given-names></string-name>, <string-name><surname>Denis</surname> <given-names>G</given-names></string-name>,, <string-name><surname>Adib</surname> <given-names>G</given-names></string-name>, <string-name><surname>Tissot</surname> <given-names>F</given-names></string-name>, <string-name><surname>Dionne</surname> <given-names>M</given-names></string-name>, <string-name><surname>De Serres</surname> <given-names>G</given-names></string-name> <article-title>Characterization and evolution of infection control practices among SARS-CoV-2 infected healthcare workers of acute care hospitals and long-term care facilities in Quebec, Canada, Spring 2020</article-title>. <source>Infect Contr Hospit Epidemiol. in press</source> <year>2021</year>;</mixed-citation></ref>
<ref id="c20"><label>20.</label><mixed-citation publication-type="journal"><string-name><surname>Landis</surname> <given-names>BN</given-names></string-name>, <string-name><surname>Frasnelli</surname> <given-names>J</given-names></string-name>, <string-name><surname>Croy</surname> <given-names>I</given-names></string-name>, <string-name><surname>Hummel</surname> <given-names>T.</given-names></string-name> <article-title>Evaluating the clinical usefulness of structured questions in parosmia assessment</article-title>. <source>Laryngoscope</source>. <month>Aug</month> <year>2010</year>;<volume>120</volume> (<issue>8</issue>):<fpage>1707</fpage>&#x2013;<lpage>13</lpage>. doi:<pub-id pub-id-type="doi">10.1002/lary.20955</pub-id></mixed-citation></ref>
<ref id="c21"><label>21.</label><mixed-citation publication-type="other"><string-name><surname>Parma</surname> <given-names>V</given-names></string-name>, <string-name><surname>Hannum</surname> <given-names>ME</given-names></string-name>, <string-name><surname>O&#x2019;Leary</surname> <given-names>M</given-names></string-name>, <string-name><surname>Pellegrino</surname> <given-names>R</given-names></string-name>, <string-name><surname>Rawson</surname> <given-names>NE</given-names></string-name>, <string-name><surname>Reed</surname> <given-names>DR</given-names></string-name>, <etal>et al.</etal> <article-title>SCENTinel 1.0: development of a rapid test to screen for smell loss</article-title>. <source>Chem Senses</source>. <month>Mar</month> 27 <year>2021</year>;doi:<pub-id pub-id-type="doi">10.1093/chemse/bjab012</pub-id></mixed-citation></ref>
<ref id="c22"><label>22.</label><mixed-citation publication-type="journal"><string-name><surname>Allen</surname> <given-names>M</given-names></string-name>, <string-name><surname>Poggiali</surname> <given-names>D</given-names></string-name>, <string-name><surname>Whitaker</surname> <given-names>K</given-names></string-name>, <string-name><surname>Marshall</surname> <given-names>T</given-names></string-name>, <string-name><surname>van Langen</surname> <given-names>J</given-names></string-name>, <string-name><surname>Kievit</surname> <given-names>R.</given-names></string-name> <article-title>Raincloud plots: a multi-platform tool for robust data visualization [version 2; peer review: 2 approved]</article-title>. <source>Wellcome Open Research</source>. <year>2021</year>;<volume>4</volume>(<issue>63</issue>)doi:<pub-id pub-id-type="doi">10.12688/wellcomeopenres.15191.2</pub-id></mixed-citation></ref>
<ref id="c23"><label>23.</label><mixed-citation publication-type="journal"><string-name><surname>Hajikhani</surname> <given-names>B</given-names></string-name>, <string-name><surname>Calcagno</surname> <given-names>T</given-names></string-name>, <string-name><surname>Nasiri</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>Jamshidi</surname> <given-names>P</given-names></string-name>, <string-name><surname>Dadashi</surname> <given-names>M</given-names></string-name>, <string-name><surname>Goudarzi</surname> <given-names>M</given-names></string-name>, <etal>et al.</etal> <article-title>Olfactory and gustatory dysfunction in COVID-19 patients: A meta-analysis study</article-title>. <source>Physiol Rep</source>. <month>Sep</month> <year>2020</year>;<volume>8</volume>(<issue>18</issue>):<fpage>e14578</fpage>. doi:<pub-id pub-id-type="doi">10.14814/phy2.14578</pub-id></mixed-citation></ref>
<ref id="c24"><label>24.</label><mixed-citation publication-type="website"><string-name><surname>Lechien</surname> <given-names>JR</given-names></string-name>, <string-name><surname>Chiesa-Estomba</surname> <given-names>CM</given-names></string-name>, <string-name><surname>Beckers</surname> <given-names>E</given-names></string-name>, <string-name><surname>Mustin</surname> <given-names>V</given-names></string-name>, <string-name><surname>Ducarme</surname> <given-names>M</given-names></string-name>, <string-name><surname>Journe</surname> <given-names>F</given-names></string-name>, <etal>et al.</etal> <article-title>Prevalence and 6-month recovery of olfactory dysfunction: a multicentre study of 1363 COVID-19 patients</article-title>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/joim.13209">https://doi.org/10.1111/joim.13209</ext-link>. <source>Journal of Internal Medicine</source>. 2021/01/05 2021;n/a (n/a) doi:<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/joim.13209">https://doi.org/10.1111/joim.13209</ext-link></mixed-citation></ref>
<ref id="c25"><label>25.</label><mixed-citation publication-type="other"><string-name><surname>Capelli</surname> <given-names>M</given-names></string-name>, <string-name><surname>Gatti</surname> <given-names>P.</given-names></string-name> <article-title>Anosmia in the first coronavirus disease 2019 outbreak in Europe: functional recovery after eight months</article-title>. <source>J Laryngol Otol</source>. <year>2021</year>:<fpage>1</fpage>&#x2013;<lpage>5</lpage>. doi:<pub-id pub-id-type="doi">10.1017/S0022215121000670</pub-id></mixed-citation></ref>
<ref id="c26"><label>26.</label><mixed-citation publication-type="journal"><string-name><surname>Landis</surname> <given-names>BN</given-names></string-name>, <string-name><surname>Frasnelli</surname> <given-names>J</given-names></string-name>, <string-name><surname>Reden</surname> <given-names>J</given-names></string-name>, <string-name><surname>Lacroix</surname> <given-names>JS</given-names></string-name>, <string-name><surname>Hummel</surname> <given-names>T.</given-names></string-name> <article-title>Differences Between Orthonasal and Retronasal Olfactory Functions in Patients With Loss of the Sense of Smell</article-title>. <source>Archives of Otolaryngology&#x2013; Head &#x0026; Neck Surgery</source>. <year>2005</year>;<volume>131</volume> (<issue>11</issue>):<fpage>977</fpage>&#x2013;<lpage>981</lpage>. doi:<pub-id pub-id-type="doi">10.1001/archotol.131.11.977</pub-id> %J Archives of Otolaryngology&#x2013;Head &#x0026; Neck Surgery</mixed-citation></ref>
<ref id="c27"><label>27.</label><mixed-citation publication-type="journal"><string-name><surname>Malaty</surname> <given-names>J</given-names></string-name>, <string-name><surname>Malaty</surname> <given-names>IA</given-names></string-name>. <article-title>Smell and taste disorders in primary care</article-title>. <source>Am Fam Physician</source>. <month>Dec</month> 15 <year>2013</year>;<volume>88</volume>(<issue>12</issue>):<fpage>852</fpage>&#x2013;<lpage>9</lpage>.</mixed-citation></ref>
<ref id="c28"><label>28.</label><mixed-citation publication-type="journal"><string-name><surname>Iannilli</surname> <given-names>E</given-names></string-name>, <string-name><surname>Leopold</surname> <given-names>DA</given-names></string-name>, <string-name><surname>Hornung</surname> <given-names>DE</given-names></string-name>, <string-name><surname>Hummel</surname> <given-names>T.</given-names></string-name> <article-title>Advances in Understanding Parosmia: An fMRI Study</article-title>. <source>ORL J Otorhinolaryngol Relat Spec</source>. <year>2019</year>;<volume>81</volume>(<issue>4</issue>):<fpage>185</fpage>&#x2013;<lpage>192</lpage>. doi:<pub-id pub-id-type="doi">10.1159/000500558</pub-id></mixed-citation></ref>
<ref id="c29"><label>29.</label><mixed-citation publication-type="journal"><string-name><surname>Liu</surname> <given-names>DT</given-names></string-name>, <string-name><surname>Sabha</surname> <given-names>M</given-names></string-name>, <string-name><surname>Damm</surname> <given-names>M</given-names></string-name>, <string-name><surname>Philpott</surname> <given-names>C</given-names></string-name>, <string-name><surname>Oleszkiewicz</surname> <given-names>A</given-names></string-name>, <string-name><surname>H&#x00E4;hner</surname> <given-names>A</given-names></string-name>, <etal>et al.</etal> <article-title>Parosmia is Associated with Relevant Olfactory Recovery After Olfactory Training</article-title>. <source>Laryngoscope</source>. <month>Mar</month> <year>2021</year>;<volume>131</volume> (<issue>3</issue>):<fpage>618</fpage>&#x2013;<lpage>623</lpage>. doi:<pub-id pub-id-type="doi">10.1002/lary.29277</pub-id></mixed-citation></ref>
<ref id="c30"><label>30.</label><mixed-citation publication-type="journal"><string-name><surname>Wang</surname> <given-names>X</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>C</given-names></string-name>, <string-name><surname>Xia</surname> <given-names>X</given-names></string-name>, <string-name><surname>Yang</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Zhou</surname> <given-names>C.</given-names></string-name> <article-title>Effect of gender on odor identification at different life stages: a meta-analysis</article-title>. <source>Rhinology</source>. <month>Oct</month> 1 <year>2019</year>;<volume>57</volume>(<issue>5</issue>):<fpage>322</fpage>&#x2013;<lpage>330</lpage>. doi:<pub-id pub-id-type="doi">10.4193/Rhin19.005</pub-id></mixed-citation></ref>
<ref id="c31"><label>31.</label><mixed-citation publication-type="journal"><string-name><surname>Sorokowski</surname> <given-names>P</given-names></string-name>, <string-name><surname>Karwowski</surname> <given-names>M</given-names></string-name>, <string-name><surname>Misiak</surname> <given-names>M</given-names></string-name>, <string-name><surname>Marczak</surname> <given-names>MK</given-names></string-name>, <string-name><surname>Dziekan</surname> <given-names>M</given-names></string-name>, <string-name><surname>Hummel</surname> <given-names>T</given-names></string-name>, <etal>et al.</etal> <article-title>Sex Differences in Human Olfaction: A Meta-Analysis</article-title>. <source>Systematic Review. 2019-February-13</source> <year>2019</year>;<volume>10</volume> (<issue>242</issue>) doi:<pub-id pub-id-type="doi">10.3389/fpsyg.2019.00242</pub-id></mixed-citation></ref>
<ref id="c32"><label>32.</label><mixed-citation publication-type="journal"><string-name><surname>Liu</surname> <given-names>J</given-names></string-name>, <string-name><surname>Pinto</surname> <given-names>JM</given-names></string-name>, <string-name><surname>Yang</surname> <given-names>L</given-names></string-name>, <string-name><surname>Li</surname> <given-names>L</given-names></string-name>, <string-name><surname>Sun</surname> <given-names>J</given-names></string-name>, <string-name><surname>Miao</surname> <given-names>X</given-names></string-name>, <etal>et al.</etal> <article-title>Gender difference in Chinese adults with post-viral olfactory disorder: a hospital-based study</article-title>. <source>Acta Otolaryngol</source>. <month>Sep</month> <year>2016</year>;<volume>136</volume> (<issue>9</issue>):<fpage>976</fpage>&#x2013;<lpage>81</lpage>. doi:<pub-id pub-id-type="doi">10.3109/00016489.2016.1172729</pub-id></mixed-citation></ref>
<ref id="c33"><label>33.</label><mixed-citation publication-type="other"><string-name><surname>Butowt</surname> <given-names>R</given-names></string-name>, <string-name><surname>von Bartheld</surname> <given-names>CS</given-names></string-name>. <article-title>Anosmia in COVID-19: Underlying Mechanisms and Assessment of an Olfactory Route to Brain Infection</article-title>. <source>Neuroscientist</source>. <year>2020</year>;doi:<pub-id pub-id-type="doi">10.1177/1073858420956905</pub-id></mixed-citation></ref>
<ref id="c34"><label>34.</label><mixed-citation publication-type="journal"><string-name><surname>Solomon</surname> <given-names>T.</given-names></string-name> <article-title>Neurological infection with SARS-CoV-2 &#x2014; the story so far</article-title>. <source>Nature Reviews Neurology</source>. 2021/02/01 <year>2021</year>;<volume>17</volume>(<issue>2</issue>):<fpage>65</fpage>&#x2013;<lpage>66</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41582-020-00453-w</pub-id></mixed-citation></ref>
<ref id="c35"><label>35.</label><mixed-citation publication-type="other"><string-name><surname>Bilinska</surname> <given-names>K</given-names></string-name>, <string-name><surname>Butowt</surname> <given-names>R.</given-names></string-name> <article-title>Anosmia in COVID-19: A Bumpy Road to Establishing a Cellular Mechanism</article-title>. <source>ACS Chem Neurosci</source>. <year>2020</year>;doi:<pub-id pub-id-type="doi">10.1021/acschemneuro.0c00406</pub-id></mixed-citation></ref>
<ref id="c36"><label>36.</label><mixed-citation publication-type="journal"><string-name><surname>Cavazzana</surname> <given-names>A</given-names></string-name>, <string-name><surname>Larsson</surname> <given-names>M</given-names></string-name>, <string-name><surname>M&#x00FC;nch</surname> <given-names>M</given-names></string-name>, <string-name><surname>H&#x00E4;hner</surname> <given-names>A</given-names></string-name>, <string-name><surname>Hummel</surname> <given-names>T.</given-names></string-name> <article-title>Postinfectious olfactory loss: A retrospective study on 791 patients</article-title>. <source>Laryngoscope</source>. <month>Jan</month> <year>2018</year>;<volume>128</volume> (<issue>1</issue>):<fpage>10</fpage>&#x2013;<lpage>15</lpage>. doi:<pub-id pub-id-type="doi">10.1002/lary.26606</pub-id></mixed-citation></ref>
<ref id="c37"><label>37.</label><mixed-citation publication-type="journal"><string-name><surname>Mullol</surname> <given-names>J</given-names></string-name>, <string-name><surname>Alobid</surname> <given-names>I</given-names></string-name>, <string-name><surname>Mari&#x00F1;o-S&#x00E1;nchez</surname> <given-names>F</given-names></string-name>, <string-name><surname>Izquierdo-Dom&#x00ED;nguez</surname> <given-names>A</given-names></string-name>, <string-name><surname>Marin</surname> <given-names>C</given-names></string-name>, <string-name><surname>Klimek</surname> <given-names>L</given-names></string-name>, <etal>et al.</etal> <article-title>The Loss of Smell and Taste in the COVID-19 Outbreak: a Tale of Many Countries</article-title>. <source>Curr Allergy Asthma Rep</source>. <year>2020</year>;<volume>20</volume>(<issue>10</issue>):<fpage>61</fpage>&#x2013;<lpage>61</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11882-020-00961-1</pub-id></mixed-citation></ref>
<ref id="c38"><label>38.</label><mixed-citation publication-type="website"><string-name><surname>Wu</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Xu</surname> <given-names>X</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Duan</surname> <given-names>J</given-names></string-name>, <string-name><surname>Hashimoto</surname> <given-names>K</given-names></string-name>, <string-name><surname>Yang</surname> <given-names>L</given-names></string-name>, <etal>et al.</etal> <article-title>Nervous system involvement after infection with COVID-19 and other coronaviruses</article-title>. <source>Brain, Behavior, and Immunity</source>. 2020/03/30/ <year>2020</year>;doi:<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.bbi.2020.03.031">https://doi.org/10.1016/j.bbi.2020.03.031</ext-link></mixed-citation></ref>
<ref id="c39"><label>39.</label><mixed-citation publication-type="journal"><string-name><surname>Gori</surname> <given-names>A</given-names></string-name>, <string-name><surname>Leone</surname> <given-names>F</given-names></string-name>, <string-name><surname>Loffredo</surname> <given-names>L</given-names></string-name>, <string-name><surname>Cinicola</surname> <given-names>BL</given-names></string-name>, <string-name><surname>Brindisi</surname> <given-names>G</given-names></string-name>, <string-name><surname>De Castro</surname> <given-names>G</given-names></string-name>, <etal>et al.</etal> <article-title>COVID-19-Related Anosmia: The Olfactory Pathway Hypothesis and Early Intervention</article-title>. <source>Front Neurol</source>. <year>2020</year>;<volume>11</volume>:<fpage>956</fpage>&#x2013;<lpage>956</lpage>. doi:<pub-id pub-id-type="doi">10.3389/fneur.2020.00956</pub-id></mixed-citation></ref>
<ref id="c40"><label>40.</label><mixed-citation publication-type="other"><string-name><surname>Meinhardt</surname> <given-names>J</given-names></string-name>, <string-name><surname>Radke</surname> <given-names>J</given-names></string-name>, <string-name><surname>Dittmayer</surname> <given-names>C</given-names></string-name>, <string-name><surname>Franz</surname> <given-names>J</given-names></string-name>, <string-name><surname>Thomas</surname> <given-names>C</given-names></string-name>, <string-name><surname>Mothes</surname> <given-names>R</given-names></string-name>, <etal>et al.</etal> <article-title>Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19</article-title>. <source>Nat Neurosci</source>. <month>Nov</month> 30 <year>2020</year>;doi:<pub-id pub-id-type="doi">10.1038/s41593-020-00758-5</pub-id></mixed-citation></ref>
<ref id="c41"><label>41.</label><mixed-citation publication-type="journal"><string-name><surname>Koyuncu</surname> <given-names>OO</given-names></string-name>, <string-name><surname>Hogue</surname> <given-names>IB</given-names></string-name>, <string-name><surname>Enquist</surname> <given-names>LW</given-names></string-name>. <article-title>Virus infections in the nervous system</article-title>. <source>Cell Host Microbe</source>. <month>Apr</month> 17 <year>2013</year>;<volume>13</volume>(<issue>4</issue>):<fpage>379</fpage>&#x2013;<lpage>93</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.chom.2013.03.010</pub-id></mixed-citation></ref>
<ref id="c42"><label>42.</label><mixed-citation publication-type="journal"><string-name><surname>Bohmwald</surname> <given-names>K</given-names></string-name>, <string-name><surname>G&#x00E1;lvez</surname> <given-names>NMS</given-names></string-name>, <string-name><surname>R&#x00ED;os</surname> <given-names>M</given-names></string-name>, <string-name><surname>Kalergis</surname> <given-names>AM</given-names></string-name>. <article-title>Neurologic Alterations Due to Respiratory Virus Infections</article-title>. <source>Front Cell Neurosci</source>. <year>2018</year>;<volume>12</volume>:<fpage>386</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fncel.2018.00386</pub-id></mixed-citation></ref>
<ref id="c43"><label>43.</label><mixed-citation publication-type="journal"><string-name><surname>Arbour</surname> <given-names>N</given-names></string-name>, <string-name><surname>Day</surname> <given-names>R</given-names></string-name>, <string-name><surname>Newcombe</surname> <given-names>J</given-names></string-name>, <string-name><surname>Talbot</surname> <given-names>PJ</given-names></string-name>. <article-title>Neuroinvasion by human respiratory coronaviruses</article-title>. <source>J Virol</source>. <month>Oct</month> <year>2000</year>;<volume>74</volume>(<issue>19</issue>):<fpage>8913</fpage>&#x2013;<lpage>21</lpage>. doi:<pub-id pub-id-type="doi">10.1128/jvi.74.19.8913-8921.2000</pub-id></mixed-citation></ref>
<ref id="c44"><label>44.</label><mixed-citation publication-type="journal"><string-name><surname>Cohen</surname> <given-names>ME</given-names></string-name>, <string-name><surname>Eichel</surname> <given-names>R</given-names></string-name>, <string-name><surname>Steiner-Birmanns</surname> <given-names>B</given-names></string-name>, <string-name><surname>Janah</surname> <given-names>A</given-names></string-name>, <string-name><surname>Ioshpa</surname> <given-names>M</given-names></string-name>, <string-name><surname>Bar-Shalom</surname> <given-names>R</given-names></string-name>, <etal>et al.</etal> <article-title>A case of probable Parkinson&#x2019;s disease after SARS-CoV-2 infection</article-title>. <source>Lancet Neurol</source>. <month>Oct</month> <year>2020</year>;<volume>19</volume>(<issue>10</issue>):<fpage>804</fpage>&#x2013;<lpage>805</lpage>. doi:<pub-id pub-id-type="doi">10.1016/s1474-4422(20)30305-7</pub-id></mixed-citation></ref>
<ref id="c45"><label>45.</label><mixed-citation publication-type="journal"><string-name><surname>Cristallo</surname> <given-names>A</given-names></string-name>, <string-name><surname>Gambaro</surname> <given-names>F</given-names></string-name>, <string-name><surname>Biamonti</surname> <given-names>G</given-names></string-name>, <string-name><surname>Ferrante</surname> <given-names>P</given-names></string-name>, <string-name><surname>Battaglia</surname> <given-names>M</given-names></string-name>, <string-name><surname>Cereda</surname> <given-names>PM</given-names></string-name>. <article-title>Human coronavirus polyadenylated RNA sequences in cerebrospinal fluid from multiple sclerosis patients</article-title>. <source>New Microbiol</source>. <month>Apr</month> <year>1997</year>;<volume>20</volume>(<issue>2</issue>):<fpage>105</fpage>&#x2013;<lpage>14</lpage>.</mixed-citation></ref>
<ref id="c46"><label>46.</label><mixed-citation publication-type="journal"><string-name><surname>Fazzini</surname> <given-names>E</given-names></string-name>, <string-name><surname>Fleming</surname> <given-names>J</given-names></string-name>, <string-name><surname>Fahn</surname> <given-names>S.</given-names></string-name> <article-title>Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson&#x2019;s disease</article-title>. <source>Mov Disord</source>. <year>1992</year>;<volume>7</volume>(<issue>2</issue>):<fpage>153</fpage>&#x2013;<lpage>8</lpage>. doi:<pub-id pub-id-type="doi">10.1002/mds.870070210</pub-id></mixed-citation></ref>
<ref id="c47"><label>47.</label><mixed-citation publication-type="journal"><string-name><surname>Johnson-Lussenburg</surname> <given-names>CM</given-names></string-name>, <string-name><surname>Zheng</surname> <given-names>Q.</given-names></string-name> <article-title>Coronavirus and multiple sclerosis: results of a case/control longitudinal serological study</article-title>. <source>Adv Exp Med Biol</source>. <year>1987</year>;<volume>218</volume>:<fpage>421</fpage>&#x2013;<lpage>9</lpage>. doi:<pub-id pub-id-type="doi">10.1007/978-1-4684-1280-2_51</pub-id></mixed-citation></ref>
<ref id="c48"><label>48.</label><mixed-citation publication-type="journal"><string-name><surname>Morris</surname> <given-names>JA</given-names></string-name>. <article-title>Clinical viral infections and multiple sclerosis</article-title>. <source>Lancet</source>. <month>Aug</month> 3 <year>1985</year>;<volume>2</volume> (<issue>8449</issue>):<fpage>273</fpage>. doi:<pub-id pub-id-type="doi">10.1016/s0140-6736(85)90318-6</pub-id></mixed-citation></ref>
<ref id="c49"><label>49.</label><mixed-citation publication-type="journal"><string-name><surname>Murray</surname> <given-names>RS</given-names></string-name>, <string-name><surname>Brown</surname> <given-names>B</given-names></string-name>, <string-name><surname>Brian</surname> <given-names>D</given-names></string-name>, <string-name><surname>Cabirac</surname> <given-names>GF</given-names></string-name>. <article-title>Detection of coronavirus RNA and antigen in multiple sclerosis brain</article-title>. <source>Ann Neurol</source>. <month>May</month> <year>1992</year>;<volume>31</volume>(<issue>5</issue>):<fpage>525</fpage>&#x2013;<lpage>33</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ana.410310511</pub-id></mixed-citation></ref>
<ref id="c50"><label>50.</label><mixed-citation publication-type="journal"><string-name><surname>Stewart</surname> <given-names>JN</given-names></string-name>, <string-name><surname>Mounir</surname> <given-names>S</given-names></string-name>, <string-name><surname>Talbot</surname> <given-names>PJ</given-names></string-name>. <article-title>Human coronavirus gene expression in the brains of multiple sclerosis patients</article-title>. <source>Virology</source>. <month>Nov</month> <year>1992</year>;<volume>191</volume> (<issue>1</issue>):<fpage>502</fpage>&#x2013;<lpage>5</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0042-6822(92)90220-j</pub-id></mixed-citation></ref>
<ref id="c51"><label>51.</label><mixed-citation publication-type="other"><string-name><surname>Taquet</surname> <given-names>M</given-names></string-name>, <string-name><surname>Geddes</surname> <given-names>JR</given-names></string-name>, <string-name><surname>Husain</surname> <given-names>M</given-names></string-name>, <string-name><surname>Luciano</surname> <given-names>S</given-names></string-name>, <string-name><surname>Harrison</surname> <given-names>PJ</given-names></string-name>. <article-title>6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records</article-title>. <source>Lancet Psychiatry</source>. <month>Apr</month> 1 <year>2021</year>;doi:<pub-id pub-id-type="doi">10.1016/s2215-0366(21)00084-5</pub-id></mixed-citation></ref>
<ref id="c52"><label>52.</label><mixed-citation publication-type="book"><string-name><surname>Schiffman</surname> <given-names>SS</given-names></string-name>. <chapter-title>Smell and Taste</chapter-title>. In: <person-group person-group-type="editor"><string-name><surname>Birren</surname> <given-names>JE</given-names></string-name></person-group>, ed. <source>Encyclopedia of Gerontology (Second Edition)</source>. <publisher-name>Elsevier</publisher-name>; <year>2007</year>:<fpage>515</fpage>&#x2013;<lpage>525</lpage>.</mixed-citation></ref>
<ref id="c53"><label>53.</label><mixed-citation publication-type="other"><string-name><surname>Gonzales</surname> <given-names>GM</given-names></string-name>, <string-name><surname>Cook</surname> <given-names>MJ</given-names></string-name>. <article-title>CHAPTER 13 - DISORDERS OF SMELL AND TASTE</article-title>. In: <person-group person-group-type="editor"><string-name><surname>Schapira</surname> <given-names>AHV</given-names></string-name>, <string-name><surname>Byrne</surname> <given-names>E</given-names></string-name>, <string-name><surname>DiMauro</surname> <given-names>S</given-names></string-name>, <etal>et al</etal></person-group>, eds. <source>Neurology and Clinical Neuroscience. Mosby</source>; <year>2007</year>:<fpage>171</fpage>&#x2013;<lpage>177</lpage>.</mixed-citation></ref>
<ref id="c54"><label>54.</label><mixed-citation publication-type="journal"><string-name><surname>Aschenbrenner</surname> <given-names>K</given-names></string-name>, <string-name><surname>Hummel</surname> <given-names>C</given-names></string-name>, <string-name><surname>Teszmer</surname> <given-names>K</given-names></string-name>, <string-name><surname>Krone</surname> <given-names>F</given-names></string-name>, <string-name><surname>Ishimaru</surname> <given-names>T</given-names></string-name>, <string-name><surname>Seo</surname> <given-names>HS</given-names></string-name>, <etal>et al.</etal> <article-title>The influence of olfactory loss on dietary behaviors</article-title>. <source>Laryngoscope</source>. <month>Jan</month> <year>2008</year>;<volume>118</volume> (<issue>1</issue>):<fpage>135</fpage>&#x2013;<lpage>44</lpage>. doi:<pub-id pub-id-type="doi">10.1097/MLG.0b013e318155a4b9</pub-id></mixed-citation></ref>
<ref id="c55"><label>55.</label><mixed-citation publication-type="journal"><string-name><surname>Mattes</surname> <given-names>R</given-names></string-name>, <string-name><surname>Cowart</surname> <given-names>B</given-names></string-name>, <string-name><surname>Schiavo</surname> <given-names>M</given-names></string-name>, <string-name><surname>Arnold</surname> <given-names>C</given-names></string-name>, <string-name><surname>Garrison</surname> <given-names>B</given-names></string-name>, <string-name><surname>Kare</surname> <given-names>M</given-names></string-name>, <etal>et al.</etal> <article-title>Dietary evaluation of patients with smell and/or taste disorders</article-title>. <source>The American journal of clinical nutrition</source>. 03/01 <year>1990</year>;<volume>51</volume>:<fpage>233</fpage>&#x2013;<lpage>40</lpage>. doi:<pub-id pub-id-type="doi">10.1093/ajcn/51.2.233</pub-id></mixed-citation></ref>
<ref id="c56"><label>56.</label><mixed-citation publication-type="journal"><string-name><surname>Kohli</surname> <given-names>P</given-names></string-name>, <string-name><surname>Soler</surname> <given-names>ZM</given-names></string-name>, <string-name><surname>Nguyen</surname> <given-names>SA</given-names></string-name>, <string-name><surname>Muus</surname> <given-names>JS</given-names></string-name>, <string-name><surname>Schlosser</surname> <given-names>RJ</given-names></string-name>. <article-title>The Association Between Olfaction and Depression: A Systematic Review</article-title>. <source>Chem Senses</source>. <month>Jul</month> <year>2016</year>;<volume>41</volume>(<issue>6</issue>):<fpage>479</fpage>&#x2013;<lpage>86</lpage>. doi:<pub-id pub-id-type="doi">10.1093/chemse/bjw061</pub-id></mixed-citation></ref>
<ref id="c57"><label>57.</label><mixed-citation publication-type="journal"><string-name><surname>Kelly</surname> <given-names>M.</given-names></string-name> <article-title>Scent of a patient: an underestimated role in clinical practice?</article-title> <source>Br J Gen Pract</source>. <year>2012</year>;<volume>62</volume> (<issue>600</issue>):<fpage>378</fpage>&#x2013;<lpage>378</lpage>. doi:<pub-id pub-id-type="doi">10.3399/bjgp12X652481</pub-id></mixed-citation></ref>
<ref id="c58"><label>58.</label><mixed-citation publication-type="journal"><string-name><surname>Sorokowska</surname> <given-names>A</given-names></string-name>, <string-name><surname>Drechsler</surname> <given-names>E</given-names></string-name>, <string-name><surname>Karwowski</surname> <given-names>M</given-names></string-name>, <string-name><surname>Hummel</surname> <given-names>T.</given-names></string-name> <article-title>Effects of olfactory training: a meta-analysis</article-title>. <source>Rhinology</source>. <month>Mar</month> 1 <year>2017</year>;<volume>55</volume>(<issue>1</issue>):<fpage>17</fpage>&#x2013;<lpage>26</lpage>. doi:<pub-id pub-id-type="doi">10.4193/Rhin16.195</pub-id></mixed-citation></ref>
<ref id="c59"><label>59.</label><mixed-citation publication-type="journal"><string-name><surname>Doty</surname> <given-names>RL</given-names></string-name>. <article-title>Treatments for smell and taste disorders: A critical review</article-title>. <source>Handb Clin Neurol</source>. <year>2019</year>;<volume>164</volume>:<fpage>455</fpage>&#x2013;<lpage>479</lpage>. doi:<pub-id pub-id-type="doi">10.1016/b978-0-444-63855-7.00025-3</pub-id></mixed-citation></ref>
<ref id="c60"><label>60.</label><mixed-citation publication-type="journal"><string-name><surname>Damm</surname> <given-names>M</given-names></string-name>, <string-name><surname>Pikart</surname> <given-names>LK</given-names></string-name>, <string-name><surname>Reimann</surname> <given-names>H</given-names></string-name>, <string-name><surname>Burkert</surname> <given-names>S</given-names></string-name>, <string-name><surname>G&#x00F6;ktas</surname> <given-names>&#x00D6;</given-names></string-name>, <string-name><surname>Haxel</surname> <given-names>B</given-names></string-name>, <etal>et al.</etal> <article-title>Olfactory training is helpful in postinfectious olfactory loss: a randomized, controlled, multicenter study</article-title>. <source>Laryngoscope</source>. <month>Apr</month> <year>2014</year>;<volume>124</volume> (<issue>4</issue>):<fpage>826</fpage>&#x2013;<lpage>31</lpage>. doi:<pub-id pub-id-type="doi">10.1002/lary.24340</pub-id></mixed-citation></ref>
<ref id="c61"><label>61.</label><mixed-citation publication-type="journal"><string-name><surname>Rumeau</surname> <given-names>C</given-names></string-name>, <string-name><surname>Nguyen</surname> <given-names>DT</given-names></string-name>, <string-name><surname>Jankowski</surname> <given-names>R.</given-names></string-name> <article-title>How to assess olfactory performance with the Sniffin&#x2019; Sticks test&#x00AE;</article-title>. <source>European Annals of Otorhinolaryngology, Head and Neck Diseases</source>. 2016/06/01/ <year>2016</year>;<volume>133</volume> (<issue>3</issue>):<fpage>203</fpage>&#x2013;<lpage>206</lpage>. doi:<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.anorl.2015.08.004">https://doi.org/10.1016/j.anorl.2015.08.004</ext-link></mixed-citation></ref>
<ref id="c62"><label>62.</label><mixed-citation publication-type="journal"><string-name><surname>Doty</surname> <given-names>RL</given-names></string-name>, <string-name><surname>Shaman</surname> <given-names>P</given-names></string-name>, <string-name><surname>Dann</surname> <given-names>M.</given-names></string-name> <article-title>Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function</article-title>. <source>Physiol Behav</source>. <month>Mar</month> <year>1984</year>;<volume>32</volume>(<issue>3</issue>):<fpage>489</fpage>&#x2013;<lpage>502</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0031-9384(84)90269-5</pub-id></mixed-citation></ref>
</ref-list>
<sec id="s6">
<title>Supplementary 1</title>
<sec id="s6a">
<title>Validation of the Chemosensory Perception Test</title>
<p>This study was reviewed and approved by the research ethics board of the Universit&#x00E9; du Quebec &#x00E0; Trois-Rivi&#x00E8;res (CER-20-268-08-01.04). All participants provided a verbal or written informed consent prior to participation.</p>
</sec>
</sec>
<sec id="s7">
<title>Experiment 1</title>
<sec id="s7a">
<title>Methods</title>
<p>Participants were recruited among previously tested groups. Olfactory testing was performed using the standardized Sniffin&#x2019; Sticks test at our laboratory from 2016 to 2019. Exclusion criteria was any perceived changes of their sense of smell since previous testing. Participants were distributed into 2 groups based on their Threshold-Discrimination-Identification (TDI) scores. The first group consists of participants with normal olfactory function (normosmia), defined as TDI scores above 30.5<sup><xref ref-type="bibr" rid="c61">61</xref></sup>. The second group had subjective olfactory dysfunction and equivalent TDI scores. Participants were administered CPT by means of a telephone interview.</p>
</sec>
<sec id="s7b">
<title>Results</title>
<p>TDI scores in the first group range from 32.5 to 41.5 (N= 19, 9 women and 10 men, age range [60-78]). TDI scores in the second group ranged from 8 to 30.25 (N= 17, 7 women and 10 men, age range [57-77]). CPT scores were positively correlated with the Sniffin&#x2019; Sticks (&#x03C1;=0.837, <italic>P</italic>&#x003C;0.001). A cut-off score of 6 at the CPT had a sensitivity of 0.765 and specificity of 0.895.</p>
</sec>
</sec>
<sec id="s8">
<title>Experiment 2</title>
</sec>
<sec id="s8a">
<title>Methods</title>
<p>Participants were recruited among previously tested groups, participants from this cross-sectional study and in the public via social media. They were administered the University of Pennsylvania Smell Identification Test (UPSIT) (which was sent by mail) and the CPT under direct supervision through videoconferencing. Participants were distributed into 2 groups based on their UPSIT scores with a score equal or less than 33 in males and 34 in females defining hyposmia<sup><xref ref-type="bibr" rid="c62">62</xref></sup>.</p>
</sec>
<sec id="s12">
<title>Results</title>
<p>UPSIT scores in the normosmic group ranged from 34 to 28 (n=29 (21 women), age range [22-73]). The hyposmic group had UPSIT scores ranging from 9 to 34 (n= 28 (21 women), age range: [22-72]). CPT scores were significantly correlated with the UPSIT score (&#x03C1;=0.377, <italic>P</italic>=0.004) in the whole group of participants. We found this correlation to be much stronger in the hyposmic group (&#x03C1;=0.702, <italic>P</italic>&#x003C;0.001).</p>
</sec>
<sec id="s13">
<title>Conclusions</title>
<p>The CPT allows for distinction between normosmia and olfactory dysfunction with high sensitivity and specificity. CPT scores are significantly correlated to UPSIT and Sniffin Sticks scores, especially in a group of individuals with olfactory dysfunction.</p>
</sec>
</back>
</article>